雷帕霉素在肝细胞癌中的研究进展

Progress of rapamycin in hepatoceUular carcinoma

肝移植是目前治疗肝细胞癌的最有效方法之一。雷帕霉素作为一种新型免疫抑制剂，已被广泛应用于肝移植中。近来研究发现，雷帕霉素在发挥免疫抑制作用的同时还具有抗肿瘤特性。这一特点使得最近关于雷帕霉素在肝细胞癌中的研究成为热点。本文就此方面做一综述。

Liver transplantation is one of the most effective treatment of hepatocellular carcinoma. And rapamycin is a new class of immunosuppressors already in use after liver transplantation. Recently, more and more studies find that rapamyein not only can exert immunosuppressive effects but also has antitumor properties. Therefore, the research about rapamycin in hepatoeellular carcinoma has become a focus. Herein, we review the progress of rapamycin in the treatment of hepatocellular carcinoma together with current results and future developments.